Liminal Biosciences is Biotechnology in Canada that focus on Liminal Biosciences Inc business. Founded in 1994. They cover business area such as Liminal Biosciences Inc, clinical-stage research, commercialization, fibrosis treatment, two segment, small molecule therapeutic, Plasma-derive therapeutic, lung, liver, kidney condition, protein, specialty plasma, addition, business, Canada, its revenue.
1994
( 30 years old in 2024 )
Liminal Biosciences Inc
-
440 Armand-Frappier Boulevard
Suite 300
Laval, Quebec H7V 4B4
Canada
Private
Liminal Biosciences Incclinical-stage researchcommercializationfibrosis treatmenttwo segmentsmall molecule therapeuticPlasma-derive therapeuticlungliverkidney conditionproteinspecialty plasmaadditionbusinessCanadaits revenue
* We use standard office opening hours in near Liminal Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Liminal Biosciences is Biotechnology business from Canada that founded in 1994 (30 years old in 2024), Liminal Biosciences business is focusing on Liminal Biosciences Inc.
Liminal Biosciences headquarter office and corporate office address is located in 440 Armand-Frappier Boulevard Suite 300 Laval, Quebec H7V 4B4 Canada.
Liminal Biosciences was founded in Canada.
In 2024, Liminal Biosciences is currently focus on Liminal Biosciences Inc sector.
Above is snippet of Google Trends for "Liminal Biosciences Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Liminal Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
